Abstract
Nearly 40% of people affected by TB in Pakistan are not diagnosed each year. Guidelines recommend screening household contacts however, not all index patients or contacts are eligible. Therefore, many contacts who may have TB disease, remain unscreened.
We conducted a prospective cohort study under programmatic conditions in Karachi, Pakistan from January 2018 - December 2019, to screen all household contacts of all TB index patients. We disaggregated these according to guidelines into eligible (those with bacteriologically confirmed pulmonary TB or children <5 years) or ineligible (those with clinically diagnosed or extrapulmonary TB ≥5 years) index patients, and eligible (children <5 years or symptomatic individuals) or ineligible (asymptomatic individuals ≥5 years) contacts. We calculated TB disease yields for different groups of index patients and contacts.
Out of 39,168 household contacts from 6,362 index patients, 21,035 completed clinical assessments for TB disease, and 416 were diagnosed with all forms TB. Household contacts of clinically diagnosed pulmonary TB patients were 26% more likely to be diagnosed with TB compared to the household contacts of bacteriologically confirmed pulmonary TB (adjusted Odds Ratio 1.26 [1.01 – 1.59] p-value:0.03). The yield of TB disease among child contacts (3.4%) was significantly higher than the yield among adult contacts (0.5%) (p-value:<0.001).
Broadening TB contact screening guidelines to include clinically diagnosed and extrapulmonary index patients ≥5 years could double the number of patients detected at a similar level of effort.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study data was collected during a program supported through a grant from The Global Fund to Fight AIDS, Tuberculosis and Malaria.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board at Interactive Research and Development
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The de-identified dataset analyzed for the current study is available from the corresponding author on reasonable request and on signing of a data-sharing agreement